Search

Neurotechnology: the next frontier

With global revenues of $110 billion last year, and an aging population, the nascent "neurotechnology" market appears poised for huge growth.

Can biotechnology embrace openness?

Open source software has broken the stranglehold of proprietary software vendors. Could the Biological Open Source initiative do the same in biotech?

Why isn't Europe working?

European biotech is a hot topic among investors. They have supported as many start-ups as in the US but have seen far from equivalent returns. So what's going on? Science|Business talks to biotechnology consultant John Hodgson.

An intellectual property gladiator

Intellectual property battles are not always settled in the marketplace. Epic, life-and-death struggles often take place in the judicial arena.

No special favours for technology institute

The controversial proposal for a new European Institute of Technology hit more political turbulence, as the EU’s research commissioner questioned whether it should receive preferential funding.

China and Intellectual Property: Good news for a change

On May 12, it was announced that that an "innovative", "homegrown" digital signal processor (DSP) chip, to be designed and manufactured in China, was a fraud. Even more interesting is that the announcement was made by not by a Western agency or international body, but by the Shanghai Jiao Tong University (SJTU).